Author

Andrea L. Neumann

Research Institute of the McGill University Health Centre

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Assay:scRNA-seq· 1 Approach:statistical model· 1

Frequent Co-Authors

Hassan DakikiD· 2 shared Isabella Angela IasenzaiD· 2 shared Josée HébertiD· 2 shared Kolja EppertiD· 2 shared Manon SabyiD· 2 shared Meaghan BoileauiD· 2 shared Patricia Arreba-Tutusaus· 2 shared Bahareh Jafari· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 43 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Hassan DakikORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Glucocorticoids reprogram human AML leukemic stem cells to promote elimination through differentiation and apoptosis

Isabella Angela Iasenza, Yi Ling Sun, LeRon Best, Hassan Dakik, Meaghan Boileau, Andrea L. Neumann, Patricia Arreba-Tutusaus, Manon Saby, Josée Hébert, Mark David Minden, Luca Cavallone, Chris Williams, Bertrand Jean-Claude, Kolja Eppert

This study shows glucocorticoids eliminate AML leukemic stem cells by inducing differentiation and apoptosis, with mechanisms involving the glucocorticoid receptor and inflammatory signatures.

bioRxiv · Sep 15, 2026 · PreprintCancer Biology

Discovery of compounds targeting human acute myeloid leukemia stem cells via a novel high-throughput screen

Isabella Angela Iasenza, Safia Safa-Tahar-Henni, Hassan Dakik, Manon Saby, Bahareh Jafari, Patricia Arreba-Tutusaus, Meaghan Boileau, Andrea L. Neumann, Josée Hébert, Sonia Cellot, Frédéric Barabé, Brian T. Wilhelm, Kolja Eppert

This study identifies compounds targeting human AML stem cells through a high-throughput screen and validates their efficacy using xenotransplantation and single-cell RNA sequencing.

bioRxiv · Sep 10, 2026 · PreprintCancer Biology